Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2006, Vol. 4 ›› Issue (1): 272-275.doi: 10.3736/jcim20070309

• Original Clinical Research • Previous Articles    

Effect of intravenous drip infusion of cyclophosphamide with high-dose Astragalus injection in treating lupus nephritis

Su Li, Jan-chun Mao, Jun-hua Gu   

  1. Department of Rheumatology , Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200030 ,China
  • Online:2006-01-20 Published:2006-01-15


To observe the effect of high-dose Astragalus injection and cyclophosphamide (CTX) on infection, urine protein and immune function of the patients with lupus nephritis.


Forty-three patients diagnosed as systemic lupus erythematosus (SLE) complicated by kidney damage and qi-deficiency syndrome were randomly divided into trial group (n=23) and control group (n=20). Patients in both groups were treated for 3 months. Intravenous drip infusion of 0.8 g CTX was administered to all patients once a month, while intravenous drip infusion of 20 ml Astragalus injection was only administered to patients in the trial group every day for 12 days in each month.


The decrease of active clinical symptom score after the treatment in the trial group was greater than that in the control group (P<0.05). The infection rates of the trial group and the control group were 4.35% and 25% respectively. The decrease of 24-hour urine protein and CD8, and the increase of red blood cell count and serum albumin in the trial group were greater than those in the control group, and there were significant differences between the two groups (P<0.05). White blood cell count in the trial group was decreased less than that in the control group after the treatment (P<0.05).


High-dose Astragalus injection used together with CTX is more effective than CTX alone in decreasing infection rate and urine protein and improving immune function for patients with lupus nephritis.

Key words: Lupus erythematosus,systemic, Lupus nephritis, Cyclophosphamide, Astragalus membranaceus, Intravenous drip

CLC Number: 

  • R593.242

Table 1

Comparison of active clinical symptom score between two groups (ヌ±S)"

Group n Active clinical symptom score
Pre-treatment 20 3.87±1.51
Post-treatment 20 2.19±1.13*
Pre-treatment 23 3.61±1.25
Post-treatment 23 1.59±0.84**

Table 2

Comparisons of 24 hour urine protein, total serum protein, and serum albumin between two groups (ヌ±S)"

Group n 24 hours urine protein (g/24 h) Serum albumin (g/L) Total serum protein (g/L)
Pre-treatment 20 3.26±1.86 30.12±6.79 58.96±13.43
Post-treatment 20 1.96±0.98** 29.97±7.21 57.28±15.33
Pre-treatment 23 3.14±1.91 27.27±8.63 57.91±15.46
Post-treatment 23 1.07±0.60 ** 34.75±5.70* 61.51±11.36

Table 3

Comparisons of blood cell count and ESR between two groups (ヌ±S)"

Group n Red blood cell ( ×1012/L) White blood cell ( ×109/L) Blood platelet ( ×109/L) ESR (mm/h)
Pre-treatment 20 3.17±0.42 5.31±0.49 149.83±47.78 77.97±22.87
Post-treatment 20 3.09±0.37 3.91±0.82* 146.12±61.27 40.77±21.61**
Pre-treatment 23 3.19±0.58 5.27±0.55 152.61±58.12 81.45±25.65
Post-treatment 23 3.69±0.43* 4.83±1.18 153.45±37.21 36.63±19.78**

Table 4

Comparison of T-cell subsets between two groups (ヌ±S)"

Group n CD3 CD4 CD8
Pre-treatment 20 73.79±18.38 36.42±11.35 39.17±14.31
Post-treatment 20 66.27±13.59 39.25±13.41 41.23±16.20
Pre-treatment 23 72.19±20.56 33.78±10.81 40.15±11.88
Post-treatment 23 68.95±18.67 37.69±11.23 33.73±12.11*
[1] 蒋明 , David Yu, 林孝义, 中华风湿病学(第1版). 北京: 华夏出版社, 2004,( 第1版):547
Jiang M, Yu D, Ling XY, et al. Chinese rheumatology(第1版). Beijing: Huaxia Publishng House, 2004,( 第1版):547
[1] Talat Albukhari, Bassem Refaat, El-Sayed Bakr, Sameh Baz, Bodour Rajab, Hossam Gadalla, Mohamed El-Boshy. Salvadora persica extract attenuates cyclophosphamide-induced hepatorenal damage by modulating oxidative stress, inflammation and apoptosis in rats. Journal of Integrative Medicine, 2022, 20(4): 348-354.
[2] Pierre Watcho, Ismaelle Rosine Mpeck, Patrick Brice Deeh Defo, Modeste Wankeu-Nya, Esther Ngadjui, Georges Romeo Bonsou Fozin, Pierre Kamtchouing, Albert Kamanyi. Cyclophosphamide-induced reproductive toxicity: Beneficial effects of Helichrysum odoratissimum (Asteraceae) in male Wistar rats. Journal of Integrative Medicine, 2019, 17(5): 366-373.
[3] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88.
Full text



[1] Wei-xiong Liang. Problems-solving strategies in clinical treatment guideline for traditional Chinese medicine and integrative medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 1-4
[2] Zhao-guo Li. Discussion on English translation of commonly used sentences in traditional Chinese medicine: part one. Journal of Chinese Integrative Medicine, 2008, 6(1): 107-110
[3] Jun Hu, Jian-ping Liu. Non-invasive physical treatments for chronic/recurrent headache. Journal of Chinese Integrative Medicine, 2008, 6(1): 31
[4] Xue-mei Liu, Qi-fu Huang, Yun-ling Zhang, Jin-li Lou, Hong-sheng Liu, Hong Zheng. Effects of Tribulus terrestris L. saponion on apoptosis of cortical neurons induced by hypoxia-reoxygenation in rats. Journal of Chinese Integrative Medicine, 2008, 6(1): 45-50
[5] . Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publication (Chinese version, part two). Journal of Chinese Integrative Medicine, 2010, 8(11): 1001-1005
[6] Daniel Weber, Janelle M Wheat, Geoffrey M Currie. Inflammation and cancer: Tumor initiation, progression and metastasis,and Chinese botanical medicines. Journal of Chinese Integrative Medicine, 2010, 8(11): 1006-1013
[7] Hong Liu , Guo-liang Zhang, Li Shen , Zhen Zeng, Bao-luo Zhou, Cheng-hai Liu, Guang Nie . Application and evaluation of a pseudotyped virus assay for screening herbs for anti-H5Nl avian influenza virus. Journal of Chinese Integrative Medicine, 2010, 8(11): 1036-1040
[8] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[9] Rui Jin, Bing Zhang. A complexity analysis of Chinese herbal property theory: the multiple formations of herbal property (Part 1). Journal of Chinese Integrative Medicine, 2012, 10(11): 1198-1205
[10] Hui-min Liu, Xian-bo Wang, Yu-juan Chang, Li-li Gu. Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis. Journal of Chinese Integrative Medicine, 2012, 10(11): 1211-1228